Human Genome Sciences autoimmune, cancer news

Human Genome said it will reduce headcount by 101 (8%) to about 1,200. The cuts will come from manufacturing, R&D and administration.

Read the full 221 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE